Literature DB >> 22416626

Bisphosphonate related osteonecrosis of the jaws: a review.

Kevin Stepaniuk1.   

Abstract

Bisphosphonate use has increased in veterinary medicine over the last decade. During this time, bisphosphonate related osteonecrosis of the jaws (BRONJ) in human patients has been identified. Only recently was a dog model for BRONJ developed for human oral surgery and medicine. Veterinary patients treated with bisphosphonates may be at an increased risk for BRONJ There has been little, to no, investigation of potential long term side-effects of bisphosphonate use in veterinary patients; potential sequelae are unknown. The history of bisphosphonates, their use, and BRONJ in veterinary patients are discussed.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22416626     DOI: 10.1177/089875641102800413

Source DB:  PubMed          Journal:  J Vet Dent        ISSN: 0898-7564            Impact factor:   0.857


  3 in total

1.  Distinctive role of 6-month teriparatide treatment on intractable bisphosphonate-related osteonecrosis of the jaw.

Authors:  K M Kim; W Park; S Y Oh; H-J Kim; W Nam; S-K Lim; Y Rhee; I H Cha
Journal:  Osteoporos Int       Date:  2014-02-20       Impact factor: 4.507

2.  Zoledronate-Associated Osteonecrosis of the Jaw in a Dog with Appendicular Osteosarcoma.

Authors:  A P Lundberg; P J Roady; A J Somrak; M E Howes; T M Fan
Journal:  J Vet Intern Med       Date:  2016-06-14       Impact factor: 3.333

3.  Medication-related osteonecrosis of the jaw after long-term bisphosphonate treatment in a cat.

Authors:  Melinda J Larson; Ashley B Oakes; Ember Epperson; Dennis J Chew
Journal:  J Vet Intern Med       Date:  2019-01-21       Impact factor: 3.333

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.